Cargando…
Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other
BACKGROUND: The highly complex pathogenesis of Type 1 Diabetes is driven by several immune cell types with both effector and regulatory characteristics, which ultimately ends in the destruction of the insulin-producing beta cells. There are multiple layers of interaction between these immune cell po...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418549/ https://www.ncbi.nlm.nih.gov/pubmed/35944899 http://dx.doi.org/10.1016/j.molmet.2022.101565 |
_version_ | 1784776971096424448 |
---|---|
author | Scherm, Martin G. Wyatt, Rebecca C. Serr, Isabelle Anz, David Richardson, Sarah J. Daniel, Carolin |
author_facet | Scherm, Martin G. Wyatt, Rebecca C. Serr, Isabelle Anz, David Richardson, Sarah J. Daniel, Carolin |
author_sort | Scherm, Martin G. |
collection | PubMed |
description | BACKGROUND: The highly complex pathogenesis of Type 1 Diabetes is driven by several immune cell types with both effector and regulatory characteristics, which ultimately ends in the destruction of the insulin-producing beta cells. There are multiple layers of interaction between these immune cell populations and the pancreatic islets. SCOPE OF REVIEW: In this review article, we aim to discuss important recent insights into the multiple layers of interaction between immune cell populations and the pancreatic islets. Specifically, we discuss the environment where immune and beta cell interactions occur, the key cell types and molecules involved, and the outcomes of these interactions. MAJOR CONCLUSIONS: Most of the molecular mechanisms underlying aberrant immune cell activation and impaired immune tolerance remain insufficiently understood, which hinders the development of efficient prevention and treatment strategies. In order to overcome this knowledge gap, a better understanding of the complex interactions of immune cells and beta cells, including both the underlying protective and pathogenic mechanisms is urgently required. |
format | Online Article Text |
id | pubmed-9418549 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-94185492022-08-28 Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other Scherm, Martin G. Wyatt, Rebecca C. Serr, Isabelle Anz, David Richardson, Sarah J. Daniel, Carolin Mol Metab Review BACKGROUND: The highly complex pathogenesis of Type 1 Diabetes is driven by several immune cell types with both effector and regulatory characteristics, which ultimately ends in the destruction of the insulin-producing beta cells. There are multiple layers of interaction between these immune cell populations and the pancreatic islets. SCOPE OF REVIEW: In this review article, we aim to discuss important recent insights into the multiple layers of interaction between immune cell populations and the pancreatic islets. Specifically, we discuss the environment where immune and beta cell interactions occur, the key cell types and molecules involved, and the outcomes of these interactions. MAJOR CONCLUSIONS: Most of the molecular mechanisms underlying aberrant immune cell activation and impaired immune tolerance remain insufficiently understood, which hinders the development of efficient prevention and treatment strategies. In order to overcome this knowledge gap, a better understanding of the complex interactions of immune cells and beta cells, including both the underlying protective and pathogenic mechanisms is urgently required. Elsevier 2022-08-06 /pmc/articles/PMC9418549/ /pubmed/35944899 http://dx.doi.org/10.1016/j.molmet.2022.101565 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Scherm, Martin G. Wyatt, Rebecca C. Serr, Isabelle Anz, David Richardson, Sarah J. Daniel, Carolin Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other |
title | Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other |
title_full | Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other |
title_fullStr | Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other |
title_full_unstemmed | Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other |
title_short | Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other |
title_sort | beta cell and immune cell interactions in autoimmune type 1 diabetes: how they meet and talk to each other |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418549/ https://www.ncbi.nlm.nih.gov/pubmed/35944899 http://dx.doi.org/10.1016/j.molmet.2022.101565 |
work_keys_str_mv | AT schermmarting betacellandimmunecellinteractionsinautoimmunetype1diabeteshowtheymeetandtalktoeachother AT wyattrebeccac betacellandimmunecellinteractionsinautoimmunetype1diabeteshowtheymeetandtalktoeachother AT serrisabelle betacellandimmunecellinteractionsinautoimmunetype1diabeteshowtheymeetandtalktoeachother AT anzdavid betacellandimmunecellinteractionsinautoimmunetype1diabeteshowtheymeetandtalktoeachother AT richardsonsarahj betacellandimmunecellinteractionsinautoimmunetype1diabeteshowtheymeetandtalktoeachother AT danielcarolin betacellandimmunecellinteractionsinautoimmunetype1diabeteshowtheymeetandtalktoeachother |